The Graded Prognostic Assessment for SCLC and NSCLC Patients With Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Radiation Oncology, Biology, Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Graded Prognostic Assessment (GPA) for Lung Cancer Patients with Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA including the Effect of Programmed Death Ligand-1 (PD-L1) and Other Prognostic Factors
Int. J. Radiat. Oncol. Biol. Phys 2022 Mar 21;[EPub Ahead of Print], PW Sperduto, B De, J Li, D Carpenter, J Kirkpatrick, M Milligan, HA Shih, T Kutuk, R Kotecha, H Higaki, M Otsuka, H Aoyama, M Bourgoin, D Roberge, S Dajani, S Sachdev, J Gainey, JM Buatti, W Breen, PD Brown, L Ni, S Braunstein, M Gallitto, TJC Wang, R Shanley, E Lou, J Shiao, LE Gaspar, S Tanabe, T Nakano, Y An, V Chiang, L Zeng, H Soliman, H Elhalawani, D Cagney, E Thomas, DH Boggs, MS Ahluwalia, MP MehtaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.